Dr. Kejian Zhang, Professor of School of Pharmaceutical Sciences of Sun Yat-sen University, Chief Scientist of South China Center for Innovative Pharmaceuticals, has over 30 years of experience in pharmaceutical R&D and administration of drug registration in China. He graduated from China Medical University(Shenyang, China), and received a PhD from School of Pharmaceutical Sciences of Chiba University (Chiba, Japan).
Dr. Zhang has been involved in pharmacology, toxicology and pharmacokinetic research at the Institue of Materia Medica Chinese Academy of Medical Science. He has also conducted collaborative research in the National Institute of Science and Technology of Korea and University Hospital of Zurich, Switzerland.
Dr. Zhang served as the deputy director of Center for Drug Eveluation and later the deputy director of Center for Medical Device Evaluation under National Medical Products Administration (PRC) for over a decade. He has extensive experiences in the technical review of new drugs and has participated in the drafting and revision of many technical guidelines and regulations for the development of new drugs and biological products.
